<DOC>
	<DOC>NCT00306891</DOC>
	<brief_summary>The purpose of this study is to determine whether food has any effect on a single dose of Cediranib (AZD2171, Recentin™)followed by an assessment of the safety and tolerability of fixed daily dosing in comparison to varying dose levels on a patient-by-patient basis.</brief_summary>
	<brief_title>Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)</brief_title>
	<detailed_description />
	<mesh_term>Cediranib</mesh_term>
	<criteria>Clinical diagnosis of advanced solid tumour. Ability to eat a high fat breakfast Poorly controlled high blood pressure. History of significant gastrointestinal problems</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Advanced solid tumours</keyword>
	<keyword>Advanced cancer</keyword>
	<keyword>tumor</keyword>
	<keyword>tumour</keyword>
	<keyword>RECENTIN</keyword>
</DOC>